Literature DB >> 22209352

Classification criteria for Sjogren's syndrome: a critical review.

Chiara Baldini1, Rosaria Talarico, Athanasios G Tzioufas, Stefano Bombardieri.   

Abstract

Over the years, several different criteria sets have been proposed for the classification of Sjögren's syndrome (SS), but none of them has been widely adopted by the scientific community until the publication of the 1993 Preliminary European Classification criteria. These Classification criteria have been largely employed both in clinical practice and in observational and interventional studies for many years. In 2002 the Preliminary European Criteria were re-examined by a joint American and European Committee. The result of this revision were the American and European Consensus Group classification criteria (AECG-criteria) which introduced more clearly defined rules for classifying patients with primary or secondary SS, and provided more precise exclusion criteria. These AECG-criteria set is now considered to be valid to ensure a specific diagnosis of SS by the vast majority of the expert in the field. To date, the AECG-criteria have been cited more than 1.304 in literature and have been used to estimate the point prevalence of the disease in several studies conducted in Greece, UK, Turkey and Norway. However, when employed in epidemiologic studies or in daily practice, the AECG-criteria have demonstrated a higher specificity (75%), but a lesser sensitivity (65.7%) in comparison to the previous Preliminary European criteria, indicating an average prevalence of pSS at ~ 0.2% in the adult population, which is far lower than previously reported. In this paper we will critically analyse the "pro and cons" of the current AECG-criteria and of the potential usefulness of some potential revisions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209352     DOI: 10.1016/j.jaut.2011.12.006

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  47 in total

Review 1.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

2.  Hepatitis C virus infection and its rheumatologic implications.

Authors:  Zeynel A Sayiner; Uzma Haque; Mohammad U Malik; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-05

3.  Diagnostic utility of Acoustic Radiation Force Impulse (ARFI) imaging in primary Sjoegren`s syndrome.

Authors:  Andreas Knopf; Benedikt Hofauer; Klaus Thürmel; Reinhard Meier; Konrad Stock; Murat Bas; Naglaa Manour
Journal:  Eur Radiol       Date:  2015-04-11       Impact factor: 5.315

Review 4.  Autoimmunity in 2011.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

5.  Quantitative assessment of oral mucosa and labial minor salivary glands in patients with Sjögren's syndrome using swept source OCT.

Authors:  Ireneusz Grulkowski; Jan K Nowak; Karol Karnowski; Paweł Zebryk; Mariusz Puszczewicz; Jaroslaw Walkowiak; Maciej Wojtkowski
Journal:  Biomed Opt Express       Date:  2013-12-16       Impact factor: 3.732

6.  Establishing Classification Tree Models in Rheumatoid Arthritis Using Combination of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Magnetic Beads.

Authors:  Dan Ma; Nana Liang; Liyun Zhang
Journal:  Front Med (Lausanne)       Date:  2021-02-24

Review 7.  Management of primary Sjögren's syndrome: recent developments and new classification criteria.

Authors:  Nicoletta Del Papa; Claudio Vitali
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-01-01       Impact factor: 5.346

Review 8.  Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis.

Authors:  DeLisa Fairweather; Michelle A Petri; Michael J Coronado; Leslie T Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-03       Impact factor: 4.473

9.  Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?

Authors:  Chiara Baldini; Andrea Delle Sedie; Nicoletta Luciano; Pasquale Pepe; Francesco Ferro; Rosaria Talarico; Chiara Tani; Marta Mosca
Journal:  Rheumatol Int       Date:  2013-10-06       Impact factor: 2.631

10.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.